Shaping Habitual Impulses For a Tobacco-free Style

ConditionsST+ABR ST+SHAM ST-only

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorUniversity of Houston

About this trial

The present investigation aims to assess the efficacy of an innovative and novel smoking cessation intervention that integrates approach bias retraining (ABR) and standard smoking cessation treatment (ST). Participants will be randomized to either: (1) standard smoking cessation treatment and approach bias retraining (ST+ABR); (2) ST+Sham; or (3) ST-only.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

At least 18 years of age

Ability to speak English fluently

Ability to read English fluently

Ability to write in English fluently

Disqualifiers

Having used an e-cigarette in the past 3 months

Having initiated any mental health therapy or pharmacotherapy within the past 3 months

Being currently in therapy for substance abuse (including nicotine dependence)

Being currently enrolled in any other studies at the RESTORE lab to help quit smoking

Trial design

Design model

Parallel

Treatments tested in this trial

ST+ABR
Behavioral
ST+ABR participants will complete seven weekly sessions of 15 minutes of computerized training (ABR), followed by a 45-minute session of standard smoking cessation treatment (CBT+NRT). Participants will be instructed to pull or push a joystick depending on the tilt, which will be positive-related or smoking-related images.
ST+Sham
Behavioral
ST+Sham participants will complete seven weekly sessions of 15 minute computerized control sessions (AAT), followed by a 45-minute session of standard smoking cessation treatment (CBT+NRT). Participants will be instructed to pull or push a joystick depending on the tilt, which will be positive-related or smoking-related images.
ST Only
Behavioral
ST Only will consist of 7 weekly 45-minute sessions of standard treatment (CBT+NRT) for smoking cessation.

Treatment groups

300 Participants

are divided into 3 treatment groups

Group A: ST+ABRExperimental treatment 1 intervention

Group B: ST+ShamSham comparator 1 intervention

Group C: ST OnlyOther 1 intervention

Trial outcomes

Primary outcomes

7-day Biochemically Verified Point Prevalence Abstinence (PPA)

PPA will be defined as no cigarette smoking within the past 7 days of assessments and will be biochemically verified via assessment of expired carbon monoxide.

Time frame

1-week, 2-week, 3-week post-quit, and 1-, 3-, and 6-month follow-ups

Prolonged Abstinence (PA)

Participants will self report their abstinence by reporting whether or not they have smoked since their quit date following a 2-week grace period.

Time frame

3-week post-quit, 1-, 3-, and 6-month follow-ups

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Houston

Lead sponsor

University of Texas at Austin

Collaborator

Source ClinicalTrials.gov

Apply now